Cannabis’s possible role in recovery from opioid dependence has been studied, but evidence does not establish it as a proven withdrawal treatment. Our detailed overview explains cannabis’s effects and risks. In a Los Angeles study, people with experience injecting opioids described cannabis sometimes helping with withdrawal-related anxiety, craving and reducing opioid use. Their experiences deserve attention in policy and healthcare.
What did researchers study?

The 2024 qualitative study, led by University of Southern California researchers, interviewed 30 people recruited through the Los Angeles community who had injected opioids. It did not test cannabis as a medicine under controlled conditions; it explored how people used it when reducing or stopping opioids.
Many faced difficult circumstances: researchers reported housing insecurity in 57%. Barriers to care and daily struggles with withdrawal were therefore important to the study.
Cannabis as possible support during withdrawal
Participants described using cannabis to ease opioid cravings, reduce anxiety or other discomfort, or cut opioid-use frequency. Some considered it easier to access than formal addiction treatment.
These accounts help explain why people combine harm-reduction approaches. The question is not simply which substance is “better”, but whether someone has an accessible option that helps at a difficult time.
Why does this approach matter?
Opioid overdoses, particularly involving fentanyl, are a major health problem. Accessible, trustworthy addiction treatment can save lives. Positive cannabis experiences justify investigating possible additional roles in wellbeing and treatment retention.
The study did not show cannabis to be a more effective or safer substitute for methadone or buprenorphine, which are evidence-based opioid-use-disorder treatments. Naloxone access also matters for reducing overdose risk. Cannabis research should complement rather than replace these measures.
What does the study not prove?
Thirty interviews cannot measure population-wide reductions in opioid use, dependence severity or overdoses, or independently establish causation. Qualitative research has a different purpose: giving voice to experiences that large statistical analyses may miss.
The authors emphasised understanding different harm-reduction tools and improving treatment access. Openness to cannabis can allow those experiences to be investigated without stigma.
Original source: Ganesh and colleagues, “Smoking weed it gets you over the hump: Cannabis co-use as a facilitator of decreased opioid use among people who inject drugs in Los Angeles, California”, Drug and Alcohol Dependence Reports, 2024, DOI 10.1016/j.dadr.2024.100257.
Illustrative featured photograph: ready made / Pexels (Pexels License).